Frank Walsh Drislane, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Status Epilepticus | 24 | 2023 | 459 | 4.410 |
Why?
|
| Electroencephalography | 47 | 2023 | 6282 | 2.480 |
Why?
|
| Neurophysiology | 13 | 2016 | 144 | 1.580 |
Why?
|
| Anticonvulsants | 20 | 2023 | 1921 | 1.240 |
Why?
|
| Neurology | 3 | 2022 | 785 | 0.750 |
Why?
|
| Seizures | 7 | 2018 | 2996 | 0.680 |
Why?
|
| Epilepsy | 12 | 2018 | 3317 | 0.680 |
Why?
|
| Societies, Medical | 11 | 2016 | 3957 | 0.610 |
Why?
|
| Clinical Clerkship | 1 | 2022 | 569 | 0.530 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2022 | 1457 | 0.510 |
Why?
|
| Practice Guidelines as Topic | 7 | 2016 | 7431 | 0.510 |
Why?
|
| Anesthetics | 2 | 2016 | 525 | 0.450 |
Why?
|
| Brain Diseases | 4 | 2015 | 1552 | 0.440 |
Why?
|
| Perceptual Disorders | 1 | 2015 | 199 | 0.420 |
Why?
|
| Patient Simulation | 1 | 2015 | 300 | 0.420 |
Why?
|
| Rural Health | 1 | 2014 | 302 | 0.410 |
Why?
|
| Terminology as Topic | 4 | 2018 | 1540 | 0.410 |
Why?
|
| Functional Laterality | 3 | 2018 | 2243 | 0.400 |
Why?
|
| Critical Care | 4 | 2015 | 2714 | 0.390 |
Why?
|
| Epilepsy, Rolandic | 1 | 2011 | 57 | 0.360 |
Why?
|
| Periodicity | 4 | 2018 | 347 | 0.320 |
Why?
|
| Monitoring, Physiologic | 9 | 2015 | 1794 | 0.320 |
Why?
|
| Students, Medical | 1 | 2022 | 1962 | 0.320 |
Why?
|
| Monitoring, Ambulatory | 2 | 2022 | 357 | 0.310 |
Why?
|
| Epilepsy, Temporal Lobe | 7 | 2005 | 390 | 0.300 |
Why?
|
| Epilepsies, Partial | 4 | 2006 | 431 | 0.250 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2005 | 46 | 0.240 |
Why?
|
| Internship and Residency | 2 | 2015 | 5943 | 0.230 |
Why?
|
| Hemianopsia | 1 | 2005 | 121 | 0.220 |
Why?
|
| Brain Death | 2 | 2016 | 360 | 0.200 |
Why?
|
| Coma | 3 | 2016 | 485 | 0.200 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2418 | 0.200 |
Why?
|
| Humans | 81 | 2023 | 766766 | 0.190 |
Why?
|
| Brain | 8 | 2018 | 27159 | 0.180 |
Why?
|
| Visual Pathways | 2 | 2005 | 554 | 0.180 |
Why?
|
| Thiopental | 2 | 1999 | 55 | 0.180 |
Why?
|
| Pentobarbital | 2 | 1999 | 153 | 0.170 |
Why?
|
| Arteriovenous Malformations | 1 | 2003 | 396 | 0.170 |
Why?
|
| Feedback | 2 | 2022 | 797 | 0.160 |
Why?
|
| Barbiturates | 1 | 1999 | 113 | 0.160 |
Why?
|
| Sexual Dysfunction, Physiological | 3 | 2010 | 364 | 0.160 |
Why?
|
| Intensive Care Units | 1 | 2011 | 3799 | 0.150 |
Why?
|
| Luteinizing Hormone | 5 | 2005 | 828 | 0.140 |
Why?
|
| Electrodes | 3 | 2016 | 610 | 0.140 |
Why?
|
| Anesthetics, Intravenous | 2 | 1999 | 396 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 5368 | 0.130 |
Why?
|
| Eclampsia | 1 | 1997 | 61 | 0.130 |
Why?
|
| Video Recording | 2 | 2016 | 976 | 0.120 |
Why?
|
| Critical Illness | 3 | 2015 | 2750 | 0.120 |
Why?
|
| Clonazepam | 1 | 2015 | 135 | 0.120 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 1996 | 132 | 0.120 |
Why?
|
| Medical Records | 3 | 2016 | 1408 | 0.120 |
Why?
|
| Spinal Cord | 1 | 2003 | 1811 | 0.120 |
Why?
|
| Medical Informatics Applications | 1 | 2016 | 180 | 0.120 |
Why?
|
| Lorazepam | 1 | 2015 | 155 | 0.120 |
Why?
|
| Africa, Western | 1 | 2014 | 160 | 0.120 |
Why?
|
| Outpatients | 1 | 2002 | 1596 | 0.110 |
Why?
|
| Midazolam | 1 | 2015 | 267 | 0.110 |
Why?
|
| Ghana | 1 | 2014 | 333 | 0.110 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1994 | 154 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2002 | 2253 | 0.100 |
Why?
|
| Hospitals, Rural | 1 | 2014 | 174 | 0.100 |
Why?
|
| Evoked Potentials | 4 | 1998 | 1050 | 0.100 |
Why?
|
| Aged, 80 and over | 13 | 2016 | 59550 | 0.100 |
Why?
|
| Spinal Puncture | 1 | 1994 | 284 | 0.100 |
Why?
|
| Adult | 39 | 2018 | 223307 | 0.100 |
Why?
|
| Emergencies | 1 | 1998 | 1223 | 0.090 |
Why?
|
| Prognosis | 7 | 2016 | 29948 | 0.090 |
Why?
|
| Colchicine | 1 | 1992 | 257 | 0.090 |
Why?
|
| Brain Waves | 1 | 2015 | 416 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2016 | 2274 | 0.090 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2005 | 706 | 0.090 |
Why?
|
| Risk Assessment | 4 | 2008 | 24295 | 0.090 |
Why?
|
| Age Distribution | 1 | 2016 | 2869 | 0.080 |
Why?
|
| Neuromuscular Diseases | 1 | 1992 | 260 | 0.080 |
Why?
|
| Testosterone | 5 | 2010 | 2495 | 0.080 |
Why?
|
| United States | 12 | 2016 | 72951 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2016 | 2659 | 0.080 |
Why?
|
| Middle Aged | 28 | 2016 | 223257 | 0.080 |
Why?
|
| Documentation | 1 | 2016 | 914 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 2015 | 1137 | 0.080 |
Why?
|
| Disease | 1 | 2014 | 675 | 0.080 |
Why?
|
| Triazines | 3 | 2006 | 311 | 0.080 |
Why?
|
| Theft | 1 | 1988 | 20 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 1999 | 1659 | 0.080 |
Why?
|
| Treatment Outcome | 8 | 2016 | 65273 | 0.080 |
Why?
|
| Female | 34 | 2016 | 396520 | 0.070 |
Why?
|
| Pre-Eclampsia | 1 | 1997 | 1256 | 0.070 |
Why?
|
| Aged | 21 | 2016 | 171343 | 0.070 |
Why?
|
| Hypogonadism | 2 | 2010 | 802 | 0.070 |
Why?
|
| Sex Hormone-Binding Globulin | 3 | 2005 | 557 | 0.070 |
Why?
|
| Brain Damage, Chronic | 1 | 2007 | 265 | 0.070 |
Why?
|
| Phenytoin | 4 | 2006 | 189 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2022 | 4858 | 0.070 |
Why?
|
| Spinal Cord Compression | 2 | 1999 | 234 | 0.070 |
Why?
|
| Headache | 1 | 1994 | 1260 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15416 | 0.060 |
Why?
|
| Aromatase Inhibitors | 1 | 2010 | 519 | 0.060 |
Why?
|
| Survival Rate | 3 | 2016 | 12825 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 1997 | 2654 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2015 | 6214 | 0.060 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2006 | 133 | 0.060 |
Why?
|
| Death, Sudden | 2 | 2004 | 301 | 0.060 |
Why?
|
| Nitriles | 1 | 2010 | 981 | 0.060 |
Why?
|
| Triazoles | 1 | 2010 | 902 | 0.060 |
Why?
|
| Male | 30 | 2016 | 364142 | 0.060 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2003 | 70 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3692 | 0.060 |
Why?
|
| Equipment and Supplies | 2 | 2016 | 273 | 0.050 |
Why?
|
| Infusions, Intravenous | 2 | 1999 | 2228 | 0.050 |
Why?
|
| Visual Field Tests | 1 | 2005 | 415 | 0.050 |
Why?
|
| Education, Medical | 1 | 2014 | 1744 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1186 | 0.050 |
Why?
|
| Menstruation Disturbances | 1 | 2003 | 140 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 14652 | 0.050 |
Why?
|
| Myocardial Contraction | 1 | 1987 | 1516 | 0.050 |
Why?
|
| Electric Stimulation Therapy | 1 | 2007 | 635 | 0.050 |
Why?
|
| Steroids | 1 | 2006 | 936 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2014 | 3242 | 0.050 |
Why?
|
| Pediatrics | 1 | 2016 | 3614 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2016 | 9357 | 0.040 |
Why?
|
| Carbamazepine | 3 | 2006 | 224 | 0.040 |
Why?
|
| Prevalence | 2 | 2016 | 15835 | 0.040 |
Why?
|
| Adolescent | 16 | 2016 | 88904 | 0.040 |
Why?
|
| Recurrence | 2 | 2007 | 8507 | 0.040 |
Why?
|
| Estradiol | 4 | 2006 | 1947 | 0.040 |
Why?
|
| Central Nervous System | 1 | 1987 | 1345 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2007 | 4853 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2003 | 702 | 0.040 |
Why?
|
| Adjuvants, Anesthesia | 1 | 1999 | 58 | 0.040 |
Why?
|
| Androgens | 1 | 2006 | 1280 | 0.040 |
Why?
|
| Diagnosis, Differential | 4 | 1999 | 12985 | 0.040 |
Why?
|
| Cohort Studies | 5 | 2015 | 41710 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 1994 | 3229 | 0.040 |
Why?
|
| Time Factors | 4 | 2009 | 40149 | 0.040 |
Why?
|
| Visual Fields | 1 | 2005 | 1063 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2016 | 4880 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2014 | 20144 | 0.040 |
Why?
|
| Risk Factors | 5 | 2016 | 74881 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2003 | 1592 | 0.030 |
Why?
|
| Oxygen | 2 | 2000 | 4251 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2009 | 9661 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2007 | 2077 | 0.030 |
Why?
|
| Switzerland | 1 | 2016 | 322 | 0.030 |
Why?
|
| Phenobarbital | 1 | 1996 | 192 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2011 | 3459 | 0.030 |
Why?
|
| Boston | 1 | 2008 | 9346 | 0.030 |
Why?
|
| Acute Disease | 1 | 2006 | 7241 | 0.030 |
Why?
|
| Age Factors | 2 | 2009 | 18397 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 1987 | 2059 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2004 | 2192 | 0.030 |
Why?
|
| Physical Stimulation | 1 | 2016 | 514 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 1994 | 315 | 0.030 |
Why?
|
| Morbidity | 1 | 1999 | 1754 | 0.030 |
Why?
|
| Migraine Disorders | 2 | 1998 | 1710 | 0.030 |
Why?
|
| Heart | 1 | 1987 | 4425 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 5536 | 0.030 |
Why?
|
| Observation | 1 | 2015 | 310 | 0.030 |
Why?
|
| Eye Movements | 1 | 1996 | 510 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2004 | 6408 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 1999 | 1469 | 0.030 |
Why?
|
| Cerebral Cortex | 3 | 1999 | 5753 | 0.030 |
Why?
|
| Visual Perception | 2 | 1991 | 1392 | 0.030 |
Why?
|
| Reference Values | 3 | 1998 | 4913 | 0.030 |
Why?
|
| Body Temperature | 1 | 2016 | 780 | 0.030 |
Why?
|
| Young Adult | 4 | 2016 | 59939 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1999 | 1479 | 0.030 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 1994 | 256 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 14762 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 1999 | 714 | 0.020 |
Why?
|
| Epilepsy, Generalized | 1 | 1994 | 181 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2006 | 39309 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2006 | 3967 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1994 | 559 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 1 | 1994 | 417 | 0.020 |
Why?
|
| Child | 5 | 2016 | 80668 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2006 | 10100 | 0.020 |
Why?
|
| Agnosia | 1 | 1991 | 67 | 0.020 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 1991 | 65 | 0.020 |
Why?
|
| Hypothermia, Induced | 1 | 2016 | 754 | 0.020 |
Why?
|
| Hypotension | 1 | 1996 | 887 | 0.020 |
Why?
|
| Geniculate Bodies | 1 | 1991 | 157 | 0.020 |
Why?
|
| Pregnancy | 3 | 1998 | 30237 | 0.020 |
Why?
|
| Incidence | 1 | 2008 | 21525 | 0.020 |
Why?
|
| Dyslexia | 1 | 1991 | 215 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2016 | 1989 | 0.020 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1991 | 263 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2010 | 551 | 0.020 |
Why?
|
| Mortality | 1 | 1999 | 2910 | 0.020 |
Why?
|
| Asthma | 1 | 1987 | 6268 | 0.020 |
Why?
|
| Androstanes | 1 | 2006 | 20 | 0.020 |
Why?
|
| Videotape Recording | 1 | 1988 | 333 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2006 | 455 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2006 | 36567 | 0.020 |
Why?
|
| Biological Availability | 1 | 2006 | 387 | 0.020 |
Why?
|
| Dehydroepiandrosterone | 1 | 2006 | 249 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2016 | 54871 | 0.020 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2006 | 193 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2016 | 42577 | 0.010 |
Why?
|
| Animals | 3 | 2008 | 168930 | 0.010 |
Why?
|
| Vision Disorders | 1 | 1991 | 1090 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15908 | 0.010 |
Why?
|
| Chlorambucil | 1 | 1982 | 42 | 0.010 |
Why?
|
| Length of Stay | 1 | 2016 | 6490 | 0.010 |
Why?
|
| Necrosis | 1 | 1987 | 1616 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1991 | 1255 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10580 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 3 | 1999 | 20708 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 6307 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 2931 | 0.010 |
Why?
|
| Lymphoma, Follicular | 1 | 1982 | 460 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 3432 | 0.010 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2000 | 270 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2004 | 2717 | 0.010 |
Why?
|
| Oximetry | 1 | 2000 | 461 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 2000 | 364 | 0.010 |
Why?
|
| Cricetinae | 1 | 2000 | 2416 | 0.010 |
Why?
|
| Glioblastoma | 1 | 1991 | 3458 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12430 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 26389 | 0.010 |
Why?
|
| Sphenoid Bone | 1 | 1996 | 176 | 0.010 |
Why?
|
| Logistic Models | 2 | 1999 | 13278 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 36461 | 0.010 |
Why?
|
| Heart Rate | 1 | 2004 | 4207 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1991 | 82 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1991 | 209 | 0.010 |
Why?
|
| Neoplasm Seeding | 1 | 1991 | 85 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1998 | 21162 | 0.010 |
Why?
|
| Aromatase | 1 | 1991 | 147 | 0.010 |
Why?
|
| Accidents | 1 | 1991 | 164 | 0.010 |
Why?
|
| Color Perception | 1 | 1991 | 211 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1991 | 9101 | 0.010 |
Why?
|
| Forecasting | 1 | 1999 | 2936 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 1990 | 318 | 0.010 |
Why?
|
| Writing | 1 | 1991 | 200 | 0.000 |
Why?
|
| Retrospective Studies | 3 | 2006 | 81635 | 0.000 |
Why?
|
| Pain Measurement | 1 | 1998 | 3576 | 0.000 |
Why?
|
| Gadolinium DTPA | 1 | 1991 | 823 | 0.000 |
Why?
|
| Autopsy | 1 | 1991 | 1011 | 0.000 |
Why?
|
| Organometallic Compounds | 1 | 1991 | 647 | 0.000 |
Why?
|
| Patient Care Team | 1 | 1999 | 2519 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1998 | 2779 | 0.000 |
Why?
|
| Medical Oncology | 1 | 1999 | 2340 | 0.000 |
Why?
|
| Aging | 1 | 2005 | 8731 | 0.000 |
Why?
|
| Gadolinium | 1 | 1991 | 964 | 0.000 |
Why?
|
| Intelligence | 1 | 1991 | 925 | 0.000 |
Why?
|
| Radiology | 1 | 1999 | 2105 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 26310 | 0.000 |
Why?
|
| Palliative Care | 1 | 1999 | 3640 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1998 | 6596 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1991 | 2714 | 0.000 |
Why?
|
| Contrast Media | 1 | 1991 | 5329 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1982 | 11218 | 0.000 |
Why?
|